Cue Biopharma Inc Q/Q di EPS
Cos'è Q/Q di EPS di Cue Biopharma Inc?
Q/Q di EPS di Cue Biopharma Inc è -24.39%
Qual è la definizione di Q/Q di EPS?
Il tasso di crescita trimestrale dell'utile, trimestre su trimestre , è l'aumento di EPS di un'azienda negli ultimi 4 trimestri rispetto alla performance dei precedenti 4 trimestri.
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Q/Q di EPS di aziende nel Health Care settore su NASDAQ rispetto a Cue Biopharma Inc
Cosa fa Cue Biopharma Inc?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
Aziende con q/q di eps simili a Cue Biopharma Inc
- Amedisys ha Q/Q di EPS di -24.84%
- Aflac ha Q/Q di EPS di -24.84%
- Portola Pharmaceuticals ha Q/Q di EPS di -24.79%
- Molson Coors Beverage ha Q/Q di EPS di -24.68%
- Frequency Therapeutics Inc ha Q/Q di EPS di -24.66%
- First American Corp ha Q/Q di EPS di -24.65%
- Cue Biopharma Inc ha Q/Q di EPS di -24.39%
- Ellington Credit Co ha Q/Q di EPS di -24.32%
- Grifols SA ha Q/Q di EPS di -24.32%
- Apollo Medical Inc ha Q/Q di EPS di -24.32%
- Alphabet Inc ha Q/Q di EPS di -24.29%
- Alphabet Inc ha Q/Q di EPS di -24.29%
- Acco Brands ha Q/Q di EPS di -24.24%